Firefly Neuroscience Inc
AIFF1.100USD
-0.020-1.79%
Close 01/09, 16:00（ET）Quotes delayed by 15 min
14.82MMarket Cap
LossP/E TTM
More Details of Firefly Neuroscience Inc Company
Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company developing neuroscientific solutions to improve brain health outcomes for patients with mental illnesses and neurological disorders. The Company has developed its FDA-510(k) cleared Brain Network Analytics software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. The Company's Brain Network Analytics is a neurophysiological assessment tool that uses artificial intelligence and machine learning to analyze electroencephalogram (EEG) data recorded during rest and cognitive activity. The BNA Platform, in conjunction with an EEG system, provides clinicians with comprehensive insights into brain function (cognition).
Firefly Neuroscience Inc Info
Ticker SymbolAIFF
Company nameFirefly Neuroscience Inc
IPO dateOct 27, 1993
CEOLipschitz (Greg)
Number of employees13
Security typeOrdinary Share
Fiscal year-endOct 27
Address1100 Military Road
CityKENMORE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code14217
Phone18882376412
Websitehttps://fireflyneuro.com/
Ticker SymbolAIFF
IPO dateOct 27, 1993
CEOLipschitz (Greg)
Company Executives of Firefly Neuroscience Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Gil Issachar
Mr. Gil Issachar
Chief Technology Officer
Chief Technology Officer
33.48K
--
Mr. Paul Krzywicki, CPA
Mr. Paul Krzywicki, CPA
Chief Financial Officer
Chief Financial Officer
2.50K
--
Mr. David (Dave) Decaprio
Mr. David (Dave) Decaprio
President, Chief Operating Officer, Director
President, Chief Operating Officer, Director
--
--
Mr. Greg Lipschitz
Mr. Greg Lipschitz
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Brian M. Posner, CPA
Mr. Brian M. Posner, CPA
Independent Director
Independent Director
--
--
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Stella Vnook
Ms. Stella Vnook
Independent Director
Independent Director
--
--
Mr. Stephen Kilmer
Mr. Stephen Kilmer
Investor Contact
Investor Contact
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Gil Issachar
Mr. Gil Issachar
Chief Technology Officer
Chief Technology Officer
33.48K
--
Mr. Paul Krzywicki, CPA
Mr. Paul Krzywicki, CPA
Chief Financial Officer
Chief Financial Officer
2.50K
--
Mr. David (Dave) Decaprio
Mr. David (Dave) Decaprio
President, Chief Operating Officer, Director
President, Chief Operating Officer, Director
--
--
Mr. Greg Lipschitz
Mr. Greg Lipschitz
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Brian M. Posner, CPA
Mr. Brian M. Posner, CPA
Independent Director
Independent Director
--
--
Dr. Arun Swarup Menawat, Ph.D.
Dr. Arun Swarup Menawat, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sat, Nov 22
Updated: Sat, Nov 22
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Johnson (David Ian)
8.28%
Windsor Private Capital LP
5.58%
The Vanguard Group, Inc.
3.73%
RJL 18 Capital Canada LP
3.70%
Lipschitz (Gregory)
3.20%
Other
75.51%
Shareholders
Shareholders
Proportion
Johnson (David Ian)
8.28%
Windsor Private Capital LP
5.58%
The Vanguard Group, Inc.
3.73%
RJL 18 Capital Canada LP
3.70%
Lipschitz (Gregory)
3.20%
Other
75.51%
Shareholder Types
Shareholders
Proportion
Individual Investor
15.15%
Corporation
14.32%
Investment Advisor
5.71%
Investment Advisor/Hedge Fund
1.14%
Bank and Trust
0.16%
Research Firm
0.04%
Hedge Fund
0.02%
Other
63.46%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
41
953.14K
7.07%
-561.98K
2025Q3
43
1.75M
5.38%
+301.68K
2025Q2
44
1.43M
3.66%
+198.96K
2025Q1
42
1.23M
2.42%
+947.99K
2024Q4
31
225.42K
2.19%
+96.08K
2024Q3
32
129.34K
1.77%
+48.43K
2024Q2
34
80.91K
5.28%
+27.65K
2024Q1
36
53.26K
5.84%
-64.35K
2023Q4
36
74.71K
3.65%
+28.83K
2023Q3
34
45.88K
3.35%
-895.00
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Johnson (David Ian)
1.12M
8.28%
+557.88K
+100.00%
Oct 22, 2024
Windsor Private Capital LP
752.72K
5.58%
-350.05K
-31.74%
Dec 31, 2025
The Vanguard Group, Inc.
503.07K
3.73%
+401.08K
+393.27%
Sep 30, 2025
RJL 18 Capital Canada LP
499.37K
3.7%
+499.37K
--
Aug 13, 2024
Lipschitz (Gregory)
431.20K
3.2%
+11.00K
+2.62%
Sep 04, 2025
Roxy Capital Corp.
424.69K
3.15%
-265.38K
-38.46%
Feb 12, 2025
Finn (Christopher)
349.22K
2.59%
-85.98K
-19.76%
Dec 31, 2024
Geode Capital Management, L.L.C.
113.32K
0.84%
-7.29K
-6.04%
Sep 30, 2025
Menawat (Arun Swarup Ph.D.)
99.41K
0.74%
--
--
Sep 04, 2025
BlackRock Institutional Trust Company, N.A.
76.12K
0.56%
+61.69K
+427.30%
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Oct 17, 2023
Merger
10→1
Oct 17, 2023
Merger
10→1
Oct 17, 2023
Merger
10→1
Oct 17, 2023
Merger
10→1
Date
Type
Ratio
Oct 17, 2023
Merger
10→1
Oct 17, 2023
Merger
10→1
Oct 17, 2023
Merger
10→1
Oct 17, 2023
Merger
10→1
FAQs
Who are the top five shareholders of Firefly Neuroscience Inc?
The top five shareholders of Firefly Neuroscience Inc are:
Johnson (David Ian) holds 1.12M shares, accounting for 8.28% of the total shares.
Windsor Private Capital LP holds 752.72K shares, accounting for 5.58% of the total shares.
The Vanguard Group, Inc. holds 503.07K shares, accounting for 3.73% of the total shares.
RJL 18 Capital Canada LP holds 499.37K shares, accounting for 3.70% of the total shares.
Lipschitz (Gregory) holds 431.20K shares, accounting for 3.20% of the total shares.
Johnson (David Ian) holds 1.12M shares, accounting for 8.28% of the total shares.
Windsor Private Capital LP holds 752.72K shares, accounting for 5.58% of the total shares.
The Vanguard Group, Inc. holds 503.07K shares, accounting for 3.73% of the total shares.
RJL 18 Capital Canada LP holds 499.37K shares, accounting for 3.70% of the total shares.
Lipschitz (Gregory) holds 431.20K shares, accounting for 3.20% of the total shares.
What are the top three shareholder types of Firefly Neuroscience Inc?
The top three shareholder types of Firefly Neuroscience Inc are:
Johnson (David Ian)
Windsor Private Capital LP
The Vanguard Group, Inc.
Johnson (David Ian)
Windsor Private Capital LP
The Vanguard Group, Inc.
How many institutions hold shares of Firefly Neuroscience Inc (AIFF)?
As of 2025Q4, 41 institutions hold shares of Firefly Neuroscience Inc, with a combined market value of approximately 953.14K, accounting for 7.07% of the total shares. Compared to 2025Q3, institutional shareholding has increased by 1.69%.
What is the biggest source of revenue for Firefly Neuroscience Inc?
In --, the -- business generated the highest revenue for Firefly Neuroscience Inc, amounting to -- and accounting for --% of total revenue.
